Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-787-9 | CAS number: 2530-87-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
(3-Chloropropyl)trimethoxysilane was tested in a combined repeated dose toxicity study with the reproduction / developmental toxicity screening test) via the inhalation route of exposure, conducted according to OECD Test Guideline 422 and in compliance with GLP (RCC, 2005). The NOAEC for reproduction toxicity was considered to be at least 100 ppm (813 mg/m3) based on no reproductive toxicity observed at the highest concentration tested.
Link to relevant study records
- Endpoint:
- one-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- GLP compliance:
- yes
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Rats were obtained from Charles River Deutschland GmbH
Animals were a minimum of 8 weeks of age at delivery. Males were 309-377 grams and females were 204-248 grams. Animals were acclimated for 7 days prior to treatment, under test conditions with an evaluation of the health status. Animals rooms were air conditioned with 10-15 air changes per hour; the environment was monitored continously with recordings of temperature and relative humidity, 12 hours artificial fluorescent light/12 hours dark with background music played at a centrally defined low volume for at least 8 hours during the light period. Animals were housed in Makrolon (R) cages with wire mesh tops and standard granulated softwood bedding. Pelleted standard rat/mouse maintenance diet was available ad libitum. Tap water from Fullinsdorf in bottles was available ad libitum. - Route of administration:
- inhalation
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- The vapour generation system consisted of a round bottomed flask that was placed in a heating device set at 30 °C. Compressed air was supplied into the glass flasks and allowed the liquid test item to equilibrate with the temperature of the walls of the container. The vapour produced passed through a pipe and was then mixed and diluted with filtered air and conveyed to the inlet of the whole-body exposure chamber. After set-up of the definitive generation system the chamber concentration and stability of CPTMO over the duration of 6 hours was determined on two occasions prior to the start of the animal exposures.
- Details on mating procedure:
- During the pairing period, rats were housed overnight with one male and one female in Makrolon pairing cages. The female was placed with the same male until mating occurred or two weeks elapsed.
- Analytical verification of doses or concentrations:
- no
- Details on analytical verification of doses or concentrations:
- The nominal atmosphere concentration was determined once daily by weighing the test item container before and after each exposure.
The weight of the test item used was divided by the total air flow volume to give the nominal concentration. The test atmosphere concentration in each chamber was determined daily, 5 times per hour per chamber during each hour of exposure. - Duration of treatment / exposure:
- Exposure period: 28 days Premating exposure period (males): 14 days Premating exposure period (females): 14 days Duration of test: until the individual day 19 post coitum
(3-Chloropropyl)trimethoxysilane was administered for 6 hours daily by whole-body vapour inhalation to male rats for 28 days and to female rats throughout the 14-day pre-pairing, pairing and gestation period until the individual day 19 post coitum. - Frequency of treatment:
- daily
- Details on study schedule:
- Premating exposure period (males): 14 days
Premating exposure period (females): 14 days
Duration of test: until day 19 post coitum
(3-Chloropropyl)trimethoxysilane was administered for 6 hours daily by whole-body vapour inhalation to male rats for 28 days and to female rats throughout the 14-day pre-pairing, pairing and gestation period until day 19 post coitum. - Dose / conc.:
- 0 ppm (nominal)
- Dose / conc.:
- 5 ppm (nominal)
- Dose / conc.:
- 25 ppm (nominal)
- Dose / conc.:
- 100 ppm (nominal)
- No. of animals per sex per dose:
- 10/sex/dose
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- Control animals were exposed to air only under the same conditions as animals exposed to the test item.
P generation males were sacrificed after they had been treated for 28 days, P generation females and pups were sacrificed on day 4 post partum. - Parental animals: Observations and examinations:
- Animals were observed twice daily for mortalities and clinical signs. Detailed clinical observations were performed once per week. A Functional Observational battery (modified Irwin screen test) was performed once during the test (males: shortly before sacrifice; females: on day 3 post-partum). Body weights and food consumption was recorded.
- Litter observations:
- The litters were examined for litter size, live birth, stillbirth and any gross anomalies. The sex ratio of the pups was recorded. Pups were weighed individually on day 0, 1 and 4 post partum. The pups were observed daily for survival and behavioural abnormalities in nesting and nursing. Dead pups and pups killed on day 4 post partum were examined macroscopically.
- Postmortem examinations (parental animals):
- Parental generation males were sacrificed after they had been treated for 28 days, parental generation females were sacrificed on day 4 post partum.
A complete gross necropsy was performed on all adult animals.
ORGAN WEIGHTS From all adult males and females the following organs were taken, trimmed and weighed: liver, heart, adrenals*, ovaries*,
thymus, uterus, kidneys*, testes*, spleen, epididymides*, seminal vesicles, with coagulating glands and their fluids(as one unit), lungs, prostate,
brain * = paired weights
TISSUE PRESERVATION The following tissues were collected from all adult males and females and preserved in neutral phosphate buffered 4% formaldehyde solution (except for testes and epididymides, which were fixed in Bouin's fixative): gross lesions, uterus, heart, brain, thymus, spinal cord, thyroid, small and large intestines (incl. Peyers Patches), trachea and lungs (preserved by inflation with fixative and then immersion), stomach, urinary bladder, liver, lymph nodes (mediastinal and mesenteric), kidneys, sciatic nerve, adrenals, bone marrow, spleen, testes, ovaries, epididymides, uterus, prostate, seminal vesicles with coagulation glands.
Full histopathology was carried out on the preserved organs and tissues of the control and high dose group animals.Examinations were extended to lower dose group animals if treatment related changes were seen in the high dose group.
For pregnant females, the number of corpora lutea and the number of implantation sites were recorded. Mated females that did not deliver were sacrificed on gestation day 24-27. Histological exam of ovaries and uterus was carried out on any females that did not give birth. Microscopic exam of the reproductive organs of all infertile males was made if necessary. - Postmortem examinations (offspring):
- Pups were sacrificed on day 4 post partum.The litters were examined for litter size, live birth, stillbirth and any gross anomalies.
- Statistics:
- Statistical Methods: Mean and standard deviation of data were calculated. Univariate one-way analysis of variance was used to assess the
significance of intergroup differences. If the variables were assumed to follow a normal distribution, the Dunnett t-test, based on a pooled variance estimate, was used for intergroup comparisons. The Steel test (rank test) was applied when the data could not be assumed to follow a normal distribution. Fisher's Exact test for 2x2 tables was applied if the variables could be dichotomized without loss of information. - Reproductive indices:
- Fertility and mating performance
Duration of gestation
Implantation rate and Post-implantation loss
Litter size at first litter check
Postnatal loss day 0 - 4 post partum - Offspring viability indices:
- Abnormal findings at first litter check and during lactation to weaning
Sex ratios
Pup weights to day 4 post partum - Clinical signs:
- no effects observed
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- not specified
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- In particular, no treatment-related histopathological findings were observed in the reproductive organs of either sex from the parental generation.
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Description (incidence and severity):
- The assessment of the integrity of the spermatogenetic cycle did not provide any evidence of impaired spermatogenesis.
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- The fertility rate was high resulting in at least 9 litters per group for evaluation of reproduction data. At all concentrations, there were no treatment-related effects on precoital time, fertility indices, mean duration of gestation, number of implantations, post-implantation loss through to scheduled sacrifice on day 4 post partum. The mean number of corpora lutea per dam (determined at necropsy) was similar in all groups and gave no indication of a test item-related effect. There were no findings, which distinguished test item-treated animals from controls.
- Key result
- Dose descriptor:
- NOAEC
- Effect level:
- >= 100 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No adverse effects observed.
- Critical effects observed:
- no
- Clinical signs:
- no effects observed
- Dermal irritation (if dermal study):
- not examined
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not examined
- Anogenital distance (AGD):
- not specified
- Nipple retention in male pups:
- not specified
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not examined
- Other effects:
- not specified
- Behaviour (functional findings):
- not specified
- Developmental immunotoxicity:
- not specified
- Key result
- Dose descriptor:
- NOAEC
- Generation:
- F1
- Effect level:
- >= 100 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No adverse effects observed.
- Critical effects observed:
- no
- Reproductive effects observed:
- no
- Conclusions:
- Exposure to (3-chloropropyl)trimethoxysilane up to and including the high concentration of 100 ppm did not result in any signs of general or reproductive toxicity of the test item. Based on these results the NOEC (no observed effect concentration) was established as >=100 ppm.
Reference
Exposure to (3-chloropropyl)trimethoxysilane up to and including the high concentration of 100 ppm did not result in any signs of
general or reproductive toxicity of the test item.
Based on these results the NOEC (no observed effect concentration) was established as >=100 ppm.
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEC
- 813 mg/m³
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Klimisch 1 score
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
The OECD 422 study is the only study available for the reproductive toxicity endpoint.
(3-Chloropropyl)trimethoxysilane was tested in a combined repeated dose toxicity study with the reproduction / developmental toxicity screening test) via the inhalation route of exposure, conducted according to OECD Test Guideline 422 and in compliance with GLP (RCC, 2005). In the study rats were treated with the test substance via whole-body inhalation exposure up to and including the highest concentration of 100 ppm. No adverse effects on reproduction were observed. Based on the results the NOAEC for reproduction was concluded to be at least 100 ppm (813 mg/m3), the highest concentration tested.
Effects on developmental toxicity
Description of key information
(3-Chloropropyl)trimethoxysilane was tested in a combined repeated dose toxicity study with the reproduction / developmental toxicity screening test) via the inhalation route of exposure, conducted according to OECD Test Guideline 422 and in compliance with GLP (RCC, 2005). The NOAEC for developmental toxicity was concluded to be at least 100 ppm (813 mg/m3) based on no effects at the highest concentration tested.
Link to relevant study records
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- GLP compliance:
- yes
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- Rats were obtained from Charles River Deutschland GmbH
Animals were a minimum of 8 weeks of age at delivery. Males were 309-377 grams and females were 204-248 grams. Animals were acclimated for 7 days prior to treatment, under test conditions with an evaluation of the health status. Animals rooms were air conditioned with 10-15 air changes per hour; the environment was monitored continously with recordings of temperature and relative humidity, 12 hours artificial fluorescent light/12 hours dark with background music played at a centrally defined low volume for at least 8 hours during the light period. Animals were housed in Makrolon (R) cages with wire mesh tops and standard granulated softwood bedding. Pelleted standard rat/mouse maintenance diet was available ad libitum. Tap water from Fullinsdorf in bottles was available ad libitum. - Route of administration:
- inhalation
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- (3-Chloropropyl)trimethoxysilane was administered for 6 hours daily by whole-body vapour inhalation to male rats for 28 days and to female rats throughout the 14-day pre-pairing, pairing and gestation period until the individual day 19 post coitum.
- Analytical verification of doses or concentrations:
- no
- Details on analytical verification of doses or concentrations:
- The nominal atmosphere concentration was determined once daily by weighing the test item container before and after each exposure. The weight of the test item used was divided by the total air flow volume to give the nominal concentration. The test atmosphere concentration in each chamber was determined daily, 5 times per hour per chamber during each hour of exposure.
- Details on mating procedure:
- During the pairing period, rats were housed overnight with one male and one female in Makrolon pairing cages. The female was placed with the same male until mating occurred or two weeks elapsed.
- Duration of treatment / exposure:
- Exposure period: 28 days
Premating exposure period (males): 14 days
Premating exposure period (females): 14 days
Duration of test: until day 19 post coitum
(3-Chloropropyl)trimethoxysilane was administered for 6 hours daily by whole-body vapour inhalation to male rats for 28 days and to female rats throughout the 14-day pre-pairing, pairing and gestation period until day 19 post coitum. - Frequency of treatment:
- daily
- Dose / conc.:
- 0 ppm
- Remarks:
- air control
- Dose / conc.:
- 5 ppm
- Dose / conc.:
- 25 ppm
- Dose / conc.:
- 100 ppm
- No. of animals per sex per dose:
- 10/sex/dose
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- Control animals were exposed to air only under the same conditions as animals exposed to the test item.
P generation males were sacrificed after they had been treated for 28 days, P generation females and pups were sacrificed on day 4 post partum. - Maternal examinations:
- Animals were observed twice daily for mortalities and clinical signs. Detailed clinical observations were performed once per week. A Functional Observational battery (modified Irwin screen test) was performed once during the test (on day 3 post-partum). Body weights and food consumption was recorded.
- Ovaries and uterine content:
- For pregnant females, the number of corpora lutea and the number of implantation sites were recorded, mated females that did not deliver were sacrificed on gestation day 24-27. Histological exam of ovaries and uterus was carried out on any females that did not give birth.
- Fetal examinations:
- Pups were sacrificed on day 4 post partum.The litters were examined for litter size, live birth, stillbirth and any gross anomalies.
- Statistics:
- Statistical Methods: Mean and standard deviation of data were calculated. Univariate one-way analysis of variance was used to assess the significance of intergroup differences. If the variables were assumed to follow a normal distribution, the Dunnett t-test, based on a pooled variance estimate, was used for intergroup comparisons. The Steel test (rank test) was applied when the data could not be assumed to follow a normal distribution. Fisher's Exact test for 2x2 tables was applied if the variables could be dichotomized without loss of information.
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- One male animal had eyes with crust during all detailed weekly clinical observations, one female had a mass i the right hip/flank region from day 6 of the pre-pairing period until day 4 of lactation.
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- One animal was found dead, however, in the histopathological examination, this dead depended on myeloid leukaemia.
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- effects observed, non-treatment-related
- Description (incidence and severity):
- A tendency towards slightly higher food consumption in the groups exposed to the test item. This higher food consumption was considered to be incidental and of no toxicological relevance.
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- no effects observed
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, non-treatment-related
- Description (incidence and severity):
- A marginally, however, statistically significant lower absolute heart weight was noted. Nevertheless, this was not statistically significantly decreased and not considered of toxicological relevance. Mean uterus weight was marginally, however, statistically significantly lower in groups 2 and 4 than in the vehicle control.
- Gross pathological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Enlarged liver, renal pelvic dilation, testes and epididymides reduced in size, spleen enlarged and discoloured mediastinal lymph node(s). However, this was not related to the test-item.
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Other effects:
- not examined
- Number of abortions:
- not specified
- Pre- and post-implantation loss:
- effects observed, non-treatment-related
- Description (incidence and severity):
- In one of the dose groups, an incidentally although statistically significant lower incidence of post-implantation loss was noted.
- Total litter losses by resorption:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Due to the incidentally lower incidence of post-implantation loss the mean number of live pups per litter was statistically significantly higher in group 2 than in the vehicle control.
- Early or late resorptions:
- not specified
- Dead fetuses:
- not specified
- Changes in pregnancy duration:
- not specified
- Changes in number of pregnant:
- not specified
- Other effects:
- not examined
- Details on maternal toxic effects:
- Maternal toxic effects:no effects
Details on maternal toxic effects:
The fertility rate was high resulting in at least 9 litters per group for evaluation of reproduction data. At all concentrations, there were
no treatment-related effects on precoital time, fertility indices, mean duration of gestation, number of implantations, post-implantation
loss through to scheduled sacrifice on day 4 post partum. The mean number of corpora lutea per dam (determined at necropsy) was
similar in all groups and gave no indication of a test item-related effect. There were no findings, which distinguished test item-treated
animals from controls. - Key result
- Dose descriptor:
- NOAEC
- Effect level:
- >= 100 ppm (nominal)
- Based on:
- test mat.
- Basis for effect level:
- other: No adverse effects observed
- Abnormalities:
- no effects observed
- Fetal body weight changes:
- no effects observed
- Description (incidence and severity):
- Mean pup weights on day 0 and day 1 post partum were unaffected by treatment with the test item. Mean pup weight development during the first 4 days post partum lactation was unaffected by treatment with the test item.
- Reduction in number of live offspring:
- not specified
- Changes in sex ratio:
- no effects observed
- Description (incidence and severity):
- Sex ratios at first litter check and on day 4 post partum were unaffected by treatment with the test item.
- Changes in litter size and weights:
- no effects observed
- Description (incidence and severity):
- Mean pup weights on day 0 and day 1 post partum were unaffected by treatment with the test item. Mean pup weight development during the first 4 days post partum lactation was unaffected by treatment with the test item.
- Changes in postnatal survival:
- not specified
- External malformations:
- no effects observed
- Description (incidence and severity):
- No abnormal findings were noted for pups at first litter check or during the first 4 days post partum. No test item-related findings were noted at macroscopical examination of pups.
- Skeletal malformations:
- no effects observed
- Description (incidence and severity):
- No abnormal findings were noted for pups at first litter check or during the first 4 days post partum. No test item-related findings were noted at macroscopical examination of pups.
- Visceral malformations:
- no effects observed
- Description (incidence and severity):
- No abnormal findings were noted for pups at first litter check or during the first 4 days post partum. No test item-related findings were noted at macroscopical examination of pups.
- Other effects:
- not examined
- Key result
- Dose descriptor:
- NOAEC
- Effect level:
- >= 100 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No adverse effects observed
- Abnormalities:
- no effects observed
- Developmental effects observed:
- no
- Conclusions:
- Exposure to (3-chloropropyl)trimethoxysilane up to and including the high concentration of 100 ppm did not result in any signs of general or reproductive toxicity of the test item. Based on these results the NOEC (no observed effect concentration) was established as >=100 ppm.
Reference
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEC
- 813 mg/m³
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Klimisch 1 score
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
The OECD 422 study is the only study available for the developmental toxicity endpoint.
(3-Chloropropyl)trimethoxysilane was tested in a combined repeated dose toxicity study with the reproduction / developmental toxicity screening test) via the inhalation route of exposure, conducted according to OECD Test Guideline 422 and in compliance with GLP (RCC, 2005). In the study rats were treated with the test substance via whole-body inhalation exposure up to and including the highest concentration of 100 ppm. No adverse effects on development were reported. Based on the results the developmental NOAEC was concluded to be at least 100 ppm (813 mg/m3), the highest concentration tested.
Justification for classification or non-classification
Based on the available information, (3-chloropropyl)trimethoxysilane is not classified for reproductive and developmental toxicity according to Regulation (EC) No 1272/2008.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
